chrisvoncsefalvay/vaers-outcomes huggingface dataset:
CHILLS; NAUSEA; HOT FLASHES; FEELING HOT AND COLD; This spontaneous report received from a patient concerned a 61 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the subject experienced hot flashes. On 05-APR-2021, the subject experienced feeling hot and cold. On 05-APR-2021, the subject experienced nausea. On 06-APR-2021, the subject experienced chills. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 98 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from hot flashes, chills, nausea, and feeling hot and cold. This report was non-serious. This case, from the same reporter is linked to 20210424684.
stomach ache; extreme dehydration; period was shifted; diarrhea; fever; allergy to cow milk; This spontaneous case was reported by a consumer and describes the occurrence of MILK ALLERGY (allergy to cow milk), ABDOMINAL PAIN UPPER (stomach ache), DEHYDRATION (extreme dehydration), MENSTRUATION IRREGULAR (period was shifted) and DIARRHOEA (diarrhea) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced MILK ALLERGY (allergy to cow milk). On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), DEHYDRATION (extreme dehydration), MENSTRUATION IRREGULAR (period was shifted), DIARRHOEA (diarrhea) and PYREXIA (fever). At the time of the report, MILK ALLERGY (allergy to cow milk) had not resolved, ABDOMINAL PAIN UPPER (stomach ache), DIARRHOEA (diarrhea) and PYREXIA (fever) outcome was unknown and DEHYDRATION (extreme dehydration) and MENSTRUATION IRREGULAR (period was shifted) had resolved.            No Concomitant medication was reported.    No treatment medications were reported.   Patient had to drink vitamin water to rehydrate.   This case was linked to MOD-2021-410127 (Patient Link).
got a flu shot and has been sick since; Initial information received on 07-Jan-2022 regarding an unsolicited valid non-serious case received from consumer/non-hcp.  This case involves Adult female patient who experienced got a flu shot and has been sick since while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by Sanofi manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date the patient developed a non-serious "got a flu shot and has been sick since" (Malaise) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported that: "Product name was not provided, since this is a public post on the Sanofi flu shot campaign, we are assuming the consumer is referring to the Sanofi flu vaccine. Reporter Commented that his sister got a flu shot and has been sick since. Reporter rephrased same as if its like, a person  dont have the flu but let if person got a shot so I would".   Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (got a flu shot and has been sick since).  At time of reporting, the outcome was Unknown for the event got a flu shot and has been sick since.
I had the usual side effects the day after the vaccine, sore arm, fatigue, achiness and slightly elevated temp. Two days after the vaccine, I had routine bloodwork. I found out that afternoon that my white blood count was lower than all my previous tests, around 2. The test was repeated one week later and it was around 4 at that time. My doctor felt that the vaccine could have caused that.
Injection was given too high on the arm, and into the bursa/tendon area. Intense pain and sharp pain began immediately, and then 4 hours later the arm was immobile. ROM was decreased, pain had increased and the pain had moved from shoulder to upper arm to elbow.
Pain, swelling to injection site, chills, and fever, vomiting less than 24 hrs after injection.
Malaise, Headade like migrane, lgiht sensitivity, nausea, vomiting (3 times), shortness of breath
2nd day after injection site (DTaP site). Swelling, redness, "caked" feeling, warm to touch. Red area approximately 4-5 cim.
Vaccinated 2/24/03. Experienced fatigue, nausea, and URI symptoms in 1st week after vaccination.  Eventually sought treatment, placed on Biaxin. Patient states she was fatigued throughout March, "legs felt like rubber."   She started Curves diet on March 13 2003.  As part of the regine, she drank a protein drink in the morning.  Components of the drink included Mrock root, Hawthorne, Ginseng, and "stimulants."  On Sat. March 15, approximately 10 am she was working on her computer when she began to suffer blurred vision.  Her head felt "heavy," her vision got worse, and she called EMS.  She was transported to ER, BP was 189/110.  She had lab testing, EKG, CXR and was eventually released from ER with a BP of 138/90.  She continued to consume the protein drink in the mornings.  On Monday March 17 while at work, her head felt "heavy" and she had someone take her BP (160/110).  She saw Dr. who prescribed Tenomin and told her to discontinue the protein drinks.  She had an echo done 1 week ago that was normal and is scheduled for a stress test on May 1.  No problems with BP recently, however in 1998 she did have elevated BP (220/130).  At that time, she saw silver spots, her head felt heavy and her ears were ringing.  She was put on Tenomin and the doctor felt her problems were related to caffeine consumption.  Also she was going through a stressful period emotionally.   She took medication for 6 months and then discontinued on her own since BP readings were normal and she felt better.  She states her recent BP problems stemmed from the smallpox vaccine.  She stated she has had out of pocket medical expenses and anticipates more.
Information has been received from a physician concerning a 11 year old female who in August 2008, was vaccinated with the first dose of GARDASIL. In August 2008, the patient experienced hives. Subsequently, the patient recovered from the hives. The physician reported that the patient had recovered. The patient sought medical attention. Additional information has been requested.
Injection site pain & tenderness General side effects of: fatigue, headache, muscle pain, chills
05/14/06 rash, swelling around site of injection extends, 15cm distal to site and 7cm wide, no fever, aching in arm, area red, warm to touch. CBC NL no evidence of infection.
Vaccine given intramuscularly to deltoid (right) - approximately 6 days after administration right deltoid swelled and became infected requiring ATB treatment.
Patient rec'd vaccines 7/8/09 and on 7/9/09 had an event that starting with high pitched scream then patient went stiff and eyes rolled back and remained stiff and unresponsive for 5-10 minutes.
Injection stung, then tender to touch, next day arm very sore to move, increase pain next 3 days, low grade temp maybe. Day 5 arm moving much better. Bruise size 50 cent.
This patient felt fine with the injection and for the 15 min following. He was dismissed to check out and make a follow up appt. While waiting in line to make his appt, he stated to his mother (who had given him a ride and stayed with him) that he felt faint. His mother shouted to staff nearby that he was going to pass out, so a staff person grabbed a chair for him. He sat in the chair, but did not fully lose consciousness. I ran to him with , told someone to get an ice pack, and asked his mother to sit in a chair next to him and place her hand on his right arm. I checked his bp at this time and it was 58/30. He was shaking all over, diaphoretic, pale,  and his muscles were weak.  He asked for water, so one was given to him, and he promptly drank the whole 16 oz bottle.  Over approximately 5 min, he came back to his normal LOC, stopped shaking and sweating, and stated that he was feeling better.  He was given a small bag of crackers and another bottle of water, which he quickly consumed before standing up. At this point, he stated that he was feeling hung over after staying out late the evening before drinking and celebrating St. Patrick's Day. Instructed him to make sure he is well hydrated before he comes for his second dose vaccination.
I am constipated; it is kind of bad constipation for two days.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69 year-old female patient received bnt162b2 (BNT162B2), administration date 19Oct2021 (Lot number: FF2590, Expiration Date: 31Dec2021) at the age of 69 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Diabetic" (unspecified if ongoing); "Blood pressure high" (unspecified if ongoing), notes: Verbatim: Blood pressure high. Concomitant medication(s) included: METFORMIN; LISINOPRIL. Vaccination history included: Bnt162b2 (First dose covid-19 vaccine, Lot no.: EN6201 , Expiry date: 30Jun2021), for Covid-19 immunization; Bnt162b2 (Second dose covid-19 vaccine, Lot no.: EN6201 , Expiry date: 30Jun2021), for Covid-19 immunization. The following information was reported: CONSTIPATION (non-serious) with onset Oct2021, outcome "unknown", described as "I am constipated; it is kind of bad constipation for two days.". Therapeutic measures were not taken as a result of constipation.  Additional information: Consumer stated, "I had my booster shot last Tuesday and I don't know if it is from that but I am constipated like for two days. I don't know if this from that or not". When Paraphrased: Consumer stated, "Yes, I think so because I am never constipated but it is kind of bad constipation for two days, today and yesterday. Patient did not receive any treatment, consumer stated, "No, I just ate ice cream and that is it." Prior to 4 weeks of COVID Vaccine, patient did not receive any other vaccine.   Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a consumer regarding himself a male patient of unknown age. No concurrent condition and historical medication was reported. On an unknown date 11 years ago approximately in 2004, the patient was vaccinated with ZOSTAVAX (dose strength was unknown). No concomitant medication was reported. On an unknown date in November 2014, the patient got the shingles for an unspecified length of time. The patient stated that he did get better, but did not give any specific information about this. No product quality complaint was involved. The outcome of shingles was reported as resolved. Causality between shingles and ZOSTAVAX was not reported. Additional information has been requested.
the influenza vaccine had made patient Ill many times; Initial information regarding an unsolicited valid non-serious case was received from a consumer (patient) via social media and transmitted to Sanofi on 17-Nov-2020.  This case involved patient an unknown age who reported that the influenza vaccine had made patient ill many times (illness).  The patient's medical history, medical treatments, vaccinations, concomitant medications and family history were not provided.   On an unknown date, the patient received INFLUENZA VACCINE (produced by unknown manufacturer lot number unknown via an unknown route in an unknown administration site prophylactic vaccination)   On an unknown date (latency unknown), the patient had ill many times (illness).   No relevant laboratory tests were reported.  It was not reported if the patient received a corrective treatment.  Event outcome was reported as Unknown for illness.  There will be no information regarding the batch number for the case.
on 9/12/21, woke with headache, numb on left side of body, dizzy, sensitive to light and sound
Swollen upper arm Shaking chills Fever (100.8 highest then took Tylenol) Swollen knees Flushed face
Systemic: Fainting / Unresponsive-Medium, Additional Details: Patient fell from chair and struck his head on the (carpeted) floor. He came to after hearing his name being called.
Patient Received the Janssen COVID-19 Vaccine as the 2nd dose; Patient Received the Janssen COVID-19 Vaccine as the 2nd dose, after receiving Moderna for; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Patient Received the Janssen COVID-19 Vaccine as the 2nd dose) and INTERCHANGE OF VACCINE PRODUCTS (Patient Received the Janssen COVID-19 Vaccine as the 2nd dose, after receiving Moderna for) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product COVID-19 VACCINE for COVID-19 immunisation.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and second dose of COVID-19 VACCINE (unknown route) 1. On an unknown date, the patient experienced PRODUCT ADMINISTRATION ERROR (Patient Received the Janssen COVID-19 Vaccine as the 2nd dose) and INTERCHANGE OF VACCINE PRODUCTS (Patient Received the Janssen COVID-19 Vaccine as the 2nd dose, after receiving Moderna for). At the time of the report, PRODUCT ADMINISTRATION ERROR (Patient Received the Janssen COVID-19 Vaccine as the 2nd dose) and INTERCHANGE OF VACCINE PRODUCTS (Patient Received the Janssen COVID-19 Vaccine as the 2nd dose, after receiving Moderna for) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications reported No concomitant medications reported
This spontaneous report as received from a physician refers to a patient of unknown age (gender not provided). On 18-JUN-2013 the patient was vaccinated with the first dose of LIQUID PEDVAXHIB (lot # and route were not provided). And after more than two months later, on 18-DEC-2012 the patient was administered with the second dose of LIQUID PEDVASHIB (lot # and route were not provided). Other suspect therapies included a dose of ACTHIB (lot # and route were not provided) on an unspecified date in March of 2013. No adverse effect reported. Additional information has been requested.
Swelling and warmth at injection site. Treated with ORAPRED BID X 3 days X ATAVAX - TID PRN
This spontaneous report as received from a nurse refers to a 42 year old male patient with hyperlipidemia and cephalosporins allergy. On 18-JUL-2014 the patient was vaccinated with the first dose of VARIVAX (Merck) subcutaneous, 0.5 ml dose, lot # K004419 and expiration date 31-MAR-2016. Concomitant therapies included LIPITOR. On 01-AUG-2014, the patient was diagnosed with chicken pox. The patient had isolated vesicular lesions on his chest, back, left arm and left hip. The patient sought medical attention by an office visit and no medical treatment was prescribed. No laboratory diagnostic studies were performed. At the time of the report the outcome the event was reported as not recovered. Additional information has been requested.
This spontaneous report as received from a pharmacist via company representative refers to a 65 year or older patient of unknown gender. The patient medical history and drug reactions or allergies were not provided. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 (dose, frequency, route, lot # and expiration date were not provided). Other suspect therapies administered on an unknown date, included PREVNAR 13 (dose, frequency, route, lot # and expiration date were not provided). On an unknown date, the patient experienced interchange of vaccine products as the patient received the dose of PNEUMOVAX 23 and four months later, the patient received one dose of PREVNAR 13. No adverse effects were noted. It was unknown if the patient sought medical attention. At the time of the report, the patient status was unknown. Additional information has been requested.
Patient was vaccinated 7-16-12. She came back to Pharmacy on 7-18-12, complaining of rash & headache. Rash was red & raised approximately 1 1/4 inch circle. I immediately call manufacturer, Merck conferred with RPh. He recommended patient see her PCP. I advised her. She did see doctor who said she had allergic reaction.
Swelling, hot at infection site, red raised like well at infection site, sore neck, bad headache, constant fever over 99.9.
This case was reported by a physician and described the occurrence of headache in a 33-year-old male subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). Concurrent medications included TRAMADOL and BACTRIM DS. On 15 January 2011 the subject received unspecified dose of BOOSTRIX at 0.5 ml in the left arm. Within a couple hours of vaccination with BOOSTRIX on 15 January 2011, the subject experienced headache and nausea. The subject was unable to work on 17 and 18 January 2011. It was reported that nausea resolved on 18 January 2011 after TRAMADOL and BACTRIM were stopped on 17 January 2011. Headache was unresolved at the time of reporting. The physician considered headache probably related to vaccination with BOOSTRIX. Nausea was not considered to be related to BOOSTRIX and the inability to work was not specified. The physician reported that the subject was going to be sent for a CT scan of his head to make sure nothing else is going on. Reporting physician stated that the subject developing a throbbing, bi-frontal, persistent headache after receiving the BOOSTRIX. The subject stated the headache recurs and additionally complained of a numb forehead. The subject has not been able to return to work as of this time due to the headache. Follow-up information received via a nurse on 11 February 2011 indicated that the events began on 15 January 2011 (the day of BOOSTRIX administration). ULTRAM and BACTRIM were given also on 15 January 2011 as treatment prophylaxis following an unspecified injury. It was reported that these medications were received via an Urgent Care and not at the reporter's office. According to follow-up, the event of headache improved somewhat with discontinuation of concurrent ULTRAM. At the time of reporting, all of the events were considered to be improved and probably related to treatment with BOOSTRIX.
stiff neck/ upper shoulder: describe as  pain shooting up to base of the head and ear.
Pt exp fever of 103 & an inject site rxn which included redness & swelling approx 6 to 8 hrs p/immun; Next day infant afebrile & doing fine;
side effects; swelling of the throat; sore throat; trouble drinking; can't eat; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Apr-2021 and was forwarded to Moderna on 19-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects), PHARYNGEAL SWELLING (swelling of the throat), OROPHARYNGEAL PAIN (sore throat), DYSPHAGIA (trouble drinking) and FEEDING DISORDER (can't eat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects), PHARYNGEAL SWELLING (swelling of the throat), OROPHARYNGEAL PAIN (sore throat), DYSPHAGIA (trouble drinking) and FEEDING DISORDER (can't eat). At the time of the report, VACCINATION COMPLICATION (side effects), PHARYNGEAL SWELLING (swelling of the throat), OROPHARYNGEAL PAIN (sore throat), DYSPHAGIA (trouble drinking) and FEEDING DISORDER (can't eat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient  second shot is 8May2021.
Developed progressive joint pain starting the day after vaccine and continuing.  She was seen by hand specialist and treated with braces  for wrist and hands and NSAIDs.  Right hand with significant pain and received cortisone injection.  Seen  on 11/11/21 and treated with prednisone and celebrex (NSAIDs causing stomach upset).
Swollen lymph node in my right armpit area that is still present, headache and chills
This spontaneous report was received from a certified medical assistant and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ, orally, lot # M031805, expiration date 07-MAR-2018 (dose was not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 47 degrees Fahrenheit for 8 hours. Data logger was involved. There were no previous temperature excursions reported. Product quality complaint (PQC) was not involved. Additional information has been requested.
PATIENT PRESENTED TO PHARMACY AND STATED THAT THE FOLLOWING DAY AFTER BEING IMMUNIZED SHE FELT CHEST TIGHTNESS, COUGHING AND WEAKNESS. SHE REFUSED MEDICAL TREATMENT AND THE SYMPTOMS HAVE SUBSIDED AT THIS POINT.
NauseaVomiting, HYPERtension, Tachycardia, chills Narrative:  per nursing report: ". reported at 1117 hours an increased heart rate and chills, vitals as follows: T97.6 BP 167/100, HR 125, O2 100%. Vitals at 1120 HR 87. Ondansetron 4mg po administered at 1127 s/p  c/o nausea, no vomiting, continued c/o chills. 1134 vitals bp 152/88, HR 112, given blanket, relaxation techniques reviewed and encouraged. At 1141 bp 146/101, HR 90, diminishing of nausea. Employee reports normal HR in the upper 50s. Reported history of htn, medication taken this AM. Discharged from COVID-19 vaccination clinic ambulatory without aid of any assistive devices. Alert and oriented during entire monitoring period."
Hand got numb lost feeling got really bad chills at 7pm felt nausaited joints hut so much and had fatigue and lost sense of smell wint to the hospital and started getting shortness of breath face got highves red hot and itchy  I recieved a shot for my joints benedrile for my face and a shot of steroids in the hospital.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On 07-JUN-2013 the patient was vaccinated with a dose of ZOSTAVAX (0.65 ml, subcutaneous), instead of VARIVAX. No adverse effect was reported. Additional information has been requested.
This spontaneous report as received from a nurse refers to a female patient of unknown age. On an unknown date, the patient was vaccinated with M-M-R II (lot, dose and route not provided). On an unknown date, the patient had a negative rubella titer. Patient had positive measles, mumps and varicella titers but, no longer had documentation of vaccinations and if she had received M-M-R II. The outcome of negative rubella test was unknown. Additional information is not expected.